Gaeta Renee

Chief Financial Officer

Gaeta Renee has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.

On the most recent filing, Gaeta Renee is listed as Chief Financial Officer at Outset Medical, Inc. Inside the rolling window, Gaeta Renee reported no open-market purchases and 2 open-market sales totaling $107K in OM. The largest disclosed transaction in the window is a sale of 17,672 OM shares on Jun 3, 2026, worth $87K.

Companies traded

Other insiders at OM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$107K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
OMSale$20KAug 18SEC ↗
OMSale$87KJun 5SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gaeta Renee made?

Gaeta Renee has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Gaeta Renee trade?

Gaeta Renee has filed SEC Form 4 disclosures for 1 company, including OM.

When was Gaeta Renee's most recent SEC Form 4 filing?

Gaeta Renee's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.

What is Gaeta Renee's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Gaeta Renee is listed as Chief Financial Officer.

What is Gaeta Renee's total buy and sell value in the current window?

Inside the rolling retention window, Gaeta Renee bought $0 and sold $107K based on SEC Form 4 filings.

What was Gaeta Renee's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 17,672 OM shares on 2026-06-03, worth $87K, per SEC Form 4 filings.